Jafron Biomedical Co.,Ltd. (SZSE: 300529)
Health Care · Health Care Equipment & Supplies · CN
CN¥15.27
+2.07% today · -31.2% 1Y
Jafron Biomedical Co.,Ltd. (SZSE: 300529) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $1.76B and employs 2,200 people.
Over the last twelve months the share price has lost 31.2%, trading between 14.73 and 22.29.
Tweenvest scores Jafron Biomedical Co.,Ltd. across four factors: quality 76/100, value 72/100, growth 0/100, dividend 33/100. Its strongest factor is quality.
300529 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.76B
- Revenue (TTM)
- $281.16M
- P/E
- 22.68
- EPS
- 0.67
- Dividend yield
- 3.41%
- Beta (5Y)
- 0.38
- 52-week high
- CN¥22.29
- 52-week low
- CN¥14.73
- Avg volume (3M)
- —
- Shares outstanding
- 774.36M
- Employees
- 2,200
- Next earnings
- —
About Jafron Biomedical Co.,Ltd.
Jafron Biomedical Co.,Ltd. engages in the research and development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.
- ISIN
- CNE100002995
- Founded
- 1989
- Listed since
- Aug 2, 2016
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vimian Group AB (publ)OM: VIMIAN | $1.85B | Skr34.95 | 0.00% |
| LeMaitre Vascular, Inc.NasdaqGM: LMAT | $1.82B | $79.64 | +0.42% |
| Angelalign Technology Inc.SEHK: 6699 | $1.81B | HK$83.20 | -0.72% |
| Shandong Pharmaceutical Glass Co.LtdSHSE: 600529 | $1.80B | CN¥18.17 | -0.16% |
| NovoCure LimitedNasdaqGS: NVCR | $1.74B | $14.22 | -4.82% |
| Poly Medicure LimitedBSE: 531768 | $1.72B | Rs1,638.35 | -4.98% |
| Shenzhen Edge Medical Co., Ltd.SEHK: 2675 | $1.71B | HK$34.46 | -1.88% |
| Embla Medical hf.CPSE: EMBLA | $1.70B | Dkr26.60 | -2.74% |
Figures last refreshed Oct 4, 2026.